Longitudinal lung cancer prediction convolutional neural network model improves the classification of indeterminate pulmonary nodules

Rafael Paez, Michael N Kammer, Aneri Balar, Dhairya A Lakhani, Michael Knight, Dianna Rowe, David Xiao, Brent E Heideman, Sanja L Antic, Heidi Chen, Sheau-Chiann Chen, Tobias Peikert, Kim L Sandler, Bennett A Landman, Stephen A Deppen, Eric L Grogan, Fabien Maldonado, Rafael Paez, Michael N Kammer, Aneri Balar, Dhairya A Lakhani, Michael Knight, Dianna Rowe, David Xiao, Brent E Heideman, Sanja L Antic, Heidi Chen, Sheau-Chiann Chen, Tobias Peikert, Kim L Sandler, Bennett A Landman, Stephen A Deppen, Eric L Grogan, Fabien Maldonado

Abstract

A deep learning model (LCP CNN) for the stratification of indeterminate pulmonary nodules (IPNs) demonstrated better discrimination than commonly used clinical prediction models. However, the LCP CNN score is based on a single timepoint that ignores longitudinal information when prior imaging studies are available. Clinically, IPNs are often followed over time and temporal trends in nodule size or morphology inform management. In this study we investigated whether the change in LCP CNN scores over time was different between benign and malignant nodules. This study used a prospective-specimen collection, retrospective-blinded-evaluation (PRoBE) design. Subjects with incidentally or screening detected IPNs 6-30 mm in diameter with at least 3 consecutive CT scans prior to diagnosis (slice thickness ≤ 1.5 mm) with the same nodule present were included. Disease outcome was adjudicated by biopsy-proven malignancy, biopsy-proven benign disease and absence of growth on at least 2-year imaging follow-up. Lung nodules were analyzed using the Optellum LCP CNN model. Investigators performing image analysis were blinded to all clinical data. The LCP CNN score was determined for 48 benign and 32 malignant nodules. There was no significant difference in the initial LCP CNN score between benign and malignant nodules. Overall, the LCP CNN scores of benign nodules remained relatively stable over time while that of malignant nodules continued to increase over time. The difference in these two trends was statistically significant. We also developed a joint model that incorporates longitudinal LCP CNN scores to predict future probability of cancer. Malignant and benign nodules appear to have distinctive trends in LCP CNN score over time. This suggests that longitudinal modeling may improve radiomic prediction of lung cancer over current models. Additional studies are needed to validate these early findings.

Conflict of interest statement

The authors declare no competing interests.

© 2023. The Author(s).

Figures

Figure 1
Figure 1
Spaghetti plot with LCP CNN score over time for benign and malignant nodules.
Figure 2
Figure 2
The predicted LCP CNN score on a square root scale overtime for benign and malignant nodules. Panel A shows the predicted LCP CNN score with time 0 representing the time of initial nodule identification. Panel B shows the predicted LCP CNN score with time 0 representing the time of final nodule diagnosis.
Figure 3
Figure 3
Dynamic predicted probabilities of event-free (non-malignant) survival for a benign patient 6 (top panel) and a malignant patient 78 (bottom panel) estimated with the joint model. The LCP CNN longitudinal score (star points) for the second visit (left panel) and the third visit (right panel) are shown. The vertical dotted lines represent the time point of the last probability. Left of the vertical line, the fitted longitudinal trajectory (solid line) is depicted. Right of the vertical line, prediction of the conditional probabilities of event-free survival (solid line) with 95% confidence intervals (dashed line).
Figure 4
Figure 4
Conditional event-free survival (probability) with 95% confidence intervals for the benign patient 6 (top panels) and the malignant patient 78 (bottom panels) at t + 3 (left panels), t + 12 (middle panels), and t + 24 months (right panels), where t represents follow up visits. In this example, benign patient 6 had six visits and malignant patient 78 had three visits.
Figure 5
Figure 5
Time-dependent AUC under four different longitudinal sub-models in the joint model for time interval (t, t + 3] (next 3 months, left panel), (t, t + 12] (next 12 months, middle panel), and (t, t + 24] (next 24 months, right panel) given the longitudinal LCP CNN scores to t = 3, 6, 12, and 24 months. The sub-model that includes the longitudinal LCP CNN scores plus the change rate performed the best among the four sub-models. Last value—last LCP CNN score, value—longitudinal LCP CNN score, slope—rate of change in LCP CNN score, value + slope—longitudinal LCP CNN score plus rate of change in LCP CNN score.

References

    1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J. Clin. 2022;72(1):7–33. doi: 10.3322/caac.21708.
    1. Gould MK, Tang T, Liu IL, Lee J, Zheng C, Danforth KN, et al. Recent trends in the identification of incidental pulmonary nodules. Am. J. Respir. Crit. Care Med. 2015;192(10):1208–1214. doi: 10.1164/rccm.201505-0990OC.
    1. Lokhandwala T, Bittoni MA, Dann RA, D'Souza AO, Johnson M, Nagy RJ, et al. Costs of diagnostic assessment for lung cancer: A medicare claims analysis. Clin Lung Cancer. 2017;18(1):e27–e34. doi: 10.1016/j.cllc.2016.07.006.
    1. Kammer MN, Massion PP. Noninvasive biomarkers for lung cancer diagnosis, where do we stand? J. Thorac. Dis. 2020;12(6):3317–3330. doi: 10.21037/jtd-2019-ndt-10.
    1. Massion PP, Antic S, Ather S, Arteta C, Brabec J, Chen H, et al. Assessing the accuracy of a deep learning method to risk stratify indeterminate pulmonary nodules. Am. J. Respir. Crit. Care Med. 2020;202(2):241–249. doi: 10.1164/rccm.201903-0505OC.
    1. Kim RY, Oke JL, Pickup LC, Munden RF, Dotson TL, Bellinger CR, et al. Artificial intelligence tool for assessment of indeterminate pulmonary nodules detected with CT. Radiology. 2022;304(3):683–691. doi: 10.1148/radiol.212182.
    1. Gould MK, Donington J, Lynch WR, Mazzone PJ, Midthun DE, Naidich DP, et al. Evaluation of individuals with pulmonary nodules: When is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e93S–e120S. doi: 10.1378/chest.12-2351.
    1. MacMahon H, Naidich DP, Goo JM, Lee KS, Leung ANC, Mayo JR, et al. Guidelines for management of incidental pulmonary nodules detected on CT Images: From the fleischner society 2017. Radiology. 2017;284(1):228–243. doi: 10.1148/radiol.2017161659.
    1. Callister ME, Baldwin DR, Akram AR, Barnard S, Cane P, Draffan J, et al. British thoracic society guidelines for the investigation and management of pulmonary nodules. Thorax. 2015;70(Suppl 2):ii1–ii54. doi: 10.1136/thoraxjnl-2015-207168.
    1. Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: Standards for study design. J. Natl. Cancer Inst. 2008;100(20):1432–1438. doi: 10.1093/jnci/djn326.
    1. Rizopoulos, D. in Joint Models for Longitudinal and Time-to-Event Data: With Applications (R: Taylor & Francis, 2012).
    1. Kamarudin AN, Cox T, Kolamunnage-Dona R. Time-dependent ROC curve analysis in medical research: Current methods and applications. BMC Med. Res. Methodol. 2017;17(1):53. doi: 10.1186/s12874-017-0332-6.
    1. Nardone V, Reginelli A, Grassi R, Boldrini L, Vacca G, D'Ippolito E, et al. Delta radiomics: A systematic review. Radiol. Med. 2021;126(12):1571–1583. doi: 10.1007/s11547-021-01436-7.
    1. Cherezov D, Hawkins SH, Goldgof DB, Hall LO, Liu Y, Li Q, et al. Delta radiomic features improve prediction for lung cancer incidence: A nested case-control analysis of the national lung screening trial. Cancer Med. 2018;7(12):6340–6356. doi: 10.1002/cam4.1852.
    1. Alahmari SS, Cherezov D, Goldgof D, Hall L, Gillies RJ, Schabath MB. Delta radiomics improves pulmonary nodule malignancy prediction in lung cancer screening. IEEE Access. 2018;6:77796–77806. doi: 10.1109/ACCESS.2018.2884126.
    1. Ardila D, Kiraly AP, Bharadwaj S, Choi B, Reicher JJ, Peng L, et al. End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat. Med. 2019;25(6):954–961. doi: 10.1038/s41591-019-0447-x.

Source: PubMed

3
Abonner